Scientists have developed an experimental electric comb that encouraged extensive hair regrowth in mice with a model of pattern hair loss, raising hopes for a future alternative to conventional treatments. The device, named Detangle, was described in a Nature Communications paper published on 3 November 2026 and has attracted international attention as the research circulated in mid-November.

The result looks remarkable: the researchers reported nearly 100% hair restoration after a month, compared with approximately 70% in a mouse group treated with topical minoxidil. But does an electric comb really reverse baldness, and what would have to happen before the technology could be used safely and effectively by people?

What did scientists invent?

The researchers created a comb-shaped bioelectronic system called Detangle.

Unlike an ordinary comb, the experimental device combines local electrical stimulation with a method of delivering specially designed molecular treatments to the skin near hair follicles.

The system’s electrodes produce an electric field while the comb moves through the hair. The researchers designed it to concentrate stimulation and improve the movement of molecules into tissues associated with hair growth.

In their published experiments, they used an animal model of androgenetic alopecia, the common form of pattern hair loss associated with genetics and sensitivity to hormones.

The device is a research prototype, not a consumer hairbrush whose clinical effectiveness has been established.

How does the electric comb work?

The technology combines three distinct elements that are intended to operate together.

First, the comb applies localized electrical stimulation near hair follicles. The researchers investigated whether this could support activity in follicular tissue.

Second, the system delivers a VEGFA plasmid, genetic material designed to encourage cells to produce a protein involved in blood-vessel growth. Improving the local blood supply could help nourish follicles.

Third, it delivers SRD5A2-targeting small interfering RNA (siRNA), a molecular tool intended to suppress production of an enzyme linked to the formation of dihydrotestosterone (DHT).

DHT is a hormone involved in androgenetic alopecia. In susceptible follicles, its effects contribute to gradual miniaturisation and thinning hair.

The reported outcome reflects the combined experimental system, rather than proof that passing electrical current through a scalp using any commercially sold comb will have the same effect.

What did the study find?

In the animal experiments, the team reported hair restoration of approximately 97.85% after one month with the complete Detangle treatment.

The comparison group treated with conventional topical minoxidil reached approximately 70% under the specific conditions of the experiment.

Those values describe hair regrowth in the mouse model. They are not a percentage of human participants who were cured, and they should not be presented as real-world effectiveness rates for people.

A difference in an animal study may be scientifically promising, but the relevance to patients depends on whether the mechanism, safety profile and results translate to human hair follicles.

The authors interpreted the combined electrostimulation and molecular delivery approach as more effective than either mechanism alone in their experimental setting.

Why is this different from existing hair-loss treatments?

Several established treatments for androgenetic alopecia work by affecting hair-follicle activity or the hormonal environment.

Topical minoxidil is commonly used to stimulate growth and prolong the active phase of hair follicles, while medications such as finasteride reduce production of DHT through an entirely different pharmacological mechanism.

Detangle approaches the problem through targeted delivery and stimulation at the scalp, combining the physical device with genetic and RNA-based molecules.

It is this integration, rather than electricity by itself, that distinguishes the published research.

The technical approach could eventually offer a new way to deliver treatment to follicles, but it also introduces further questions about manufacturing, dosing, molecular stability and long-term effects.

Has the comb been tested on humans?

No human clinical trial demonstrating Detangle’s effectiveness was identified in the research published on 3 November 2026.

The headline results concern mice, including animals with experimentally induced features resembling pattern hair loss.

Human scalps differ in skin thickness, follicle biology, immune response, hormonal environment and the length of the hair-growth cycle.

A device that moves molecules into mouse skin may need substantial redesign and testing to establish how it performs in people.

Human studies would also need to determine whether the genetic and RNA-based components are delivered consistently and whether there are unwanted effects.

Until such work is completed, statements that the system cures baldness in humans would go beyond the evidence.

Is Detangle available to buy?

Detangle is an experimental research system. The published paper does not establish that it is available as an approved clinical hair-loss treatment.

Commercial websites may already sell products advertised as electric hair-growth combs, scalp stimulators or laser brushes. Those devices should not automatically be equated with the system described in the study.

The Detangle method requires a particular arrangement of electrodes and experimental molecular treatments. A generic powered comb does not recreate that intervention simply by producing a current.

Before considering treatment, consumers should distinguish peer-reviewed laboratory results from evidence for the exact product being offered.

The existence of a scientific paper is not proof that a product advertised using similar language has passed clinical evaluation.

Are there safety concerns?

Yes, multiple safety questions remain open. Researchers would need to assess local irritation, unintended tissue effects, the stability and distribution of genetic material, and the long-term consequences of suppressing the targeted enzyme in relevant cells.

The electrical component would also need testing for safe use under ordinary conditions.

These questions do not mean the technology is inherently unsafe. They explain why convincing results in mice are only an early stage in evaluating a potential medical device.

Regulatory approval, if sought in the future, would depend on evidence relevant to the exact treatment and jurisdiction.

Applying untested electrical equipment or genetic materials to the scalp outside controlled research is not an established alternative to medical care.

What happens next in hair-regrowth research?

The next scientific questions involve reproducing the results, understanding the relative contribution of each component and studying safety in more clinically relevant models.

If those investigations are successful, researchers could consider carefully designed human trials.

A human trial would need clear measures such as hair density, thickness, patient-reported outcomes, treatment tolerance and durability after stopping treatment.

The most useful comparison would be with appropriate established therapies under equivalent conditions, rather than assuming the mouse percentages carry directly into human treatment.

What should people understand about the electric comb study?

The result is an important experimental finding, not a proven consumer treatment. A team publishing in Nature Communications reported around 97.85% hair restoration in mice using an electric comb that delivered two molecular interventions while stimulating the follicles.

The work offers a possible new research direction for androgenetic alopecia, but human effectiveness, safety, availability and long-term benefits remain unknown.

For readers searching “electric comb for hair growth” in November 2026, the essential detail is that the promising evidence comes from an animal study of a complex prototype, rather than from clinical trials of an ordinary electric comb.